16 May 2023
Lifetime management - Tailoring treatment options to secure future possibilities
Sponsored by Boston Scientific
Anchorperson:
D. Hildick-Smith
Spokesperson:
N. Van Mieghem
Summary
Check out this session if you want to better understand the importance of paravalvular leaks and conduction disorders after TAVI on long-term outcomes. You will also learn about the latest data on the lifetime management of patients with aortic stenosis, and value the importance of TAVI design on durability and TAV-in-TAV options.
Learning Objectives
- To understand the importance of paravalvular leak and conduction disorders after TAVI on long-term outcomes
- To review the latest evidence related to lifetime management of patients with aortic stenosis
- To appreciate the importance of TAVI design on durability and TAV-in-TAV options
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)